Related Experiment Videos
Biologic therapies for dyslipidemia.
1Department of Preventive Cardiology, Rush University Medical Center, 1725 West Harrison Street, Suite 1159, Chicago, IL 60612, USA. michaeldavidson@radiantresearch.com
Current Atherosclerosis Reports
|December 10, 2003
Summary
Biologic therapies show promise for treating atherosclerosis. Advanced treatments like apolipoprotein mimetics reduce plaque buildup, with gene therapies on the horizon.
Area of Science:
- Cardiovascular Medicine
- Biotechnology
Background:
- Atherosclerosis is a significant cardiovascular disease.
- Current treatments have limitations.
- Biologic therapies offer novel treatment strategies.
Purpose of the Study:
- To review current biologic therapies for atherosclerosis.
- To highlight advanced treatments in clinical development.
Main Methods:
- Review of clinical trials and preclinical studies.
- Focus on apolipoprotein mimetics and autoimmunization.
- Exploration of emerging gene therapies.
Main Results:
- Apolipoprotein mimetics (e.g., ApoA-1 Milano) reduce atherosclerotic development.
- Autoimmunization against cholesteryl ester transfer protein is in human trials.
- Gene therapies aim to modify lipoprotein levels.
Conclusions:
- Biologic therapies, particularly apolipoprotein mimetics, demonstrate efficacy in reducing atherosclerosis.
- Further research is needed for gene therapy vector development.